Previously known as Oceanix Biosciences Corporation, and actively involved in SBIR until its acqusition in late 2005 by Caliper Life Sciences. Soon after, the management changed its name to NovaScreen Biosciences Corporation and operated as a subsidiary of Caliper Life Sciences, Inc. A biotechnology company, NovaSreen provides drug discovery and development services and products primarily organized around vitro screening assays and insilico predictive screening tools. Te firm's research efforts primarily engaged the application of molecular biology-based screening technology for the discovery and development of natural products derived from marine bacteria and other marine organisms. The companyÂ's pharmacoinformatics products include Receptor Selectivity Mapping Database (RSMDB) that provides service through the RSMDB profile and through collaborative research and development programs. NovaScreen Biosciences Corporation
